Replies to post #95843 on Biotech Values

[DewDiligence]

An increase in M&A activity is clearly good for the targets, but is it good for the large-cap acquirers?

In many cases, no, but the devil is in the details. The PFE-WYE and MRK-SGP mergers were highly accretive to shareholder value, IMO. Both PFE and MRK were woefully under-leveraged prior to these deals.